Supplements

Intranasal dexmedetomidine improves postoperative sleep quality in adult surgical patients

Intranasal dexmedetomidine significantly improved subjective and objective postoperative sleep outcomes compared to placebo or other controls. Sleep efficiency and total sleep time increased, sleep latency reduced, and the risk of sleep disturbance decreased by 47% (RR=0.53).

Last updated: Aug 6, 2026•0 RCTs•1 Meta-analyses•📖 Read as article →

Evidence Score

Evidence Score63/100
Human RCT☆☆☆☆☆
Meta-analysis★★★☆☆
Mechanism★★★★★
Safety★★★★☆
Confidencelow

Study Evidence

Study 1. Effects of intranasal dexmedetomidine on postoperative sleep quality: a systematic review and meta-analysis of randomized controlled trials.

meta

Zhao J, Zhang C, Li H, Qiu Y, Li J, Cao H, Zhou X, Guan S, Wang J, Yao M · Frontiers in medicine (2026)

Participants: 15
Duration: N/A
Intervention: Intranasal dexmedetomidine administered perioperatively
Outcome: Postoperative sleep quality (subjective scores, sleep efficiency, total sleep time, sleep latency, REM/N1/N3 sleep, sleep disturbance incidence)
Effect Size: SMD=-1.29 (lower score=better sleep), SMD=1.75 (higher score=better sleep), SMD=1.71 for sleep efficiency, SMD=1.76 for total sleep time, SMD=-1.07 for sleep latency, RR=0.53 for sleep disturbance
Population: Adult surgical patients undergoing various surgeries

Result: Intranasal dexmedetomidine significantly improved subjective and objective postoperative sleep outcomes compared to placebo or other controls. Sleep efficiency and total sleep time increased, sleep latency reduced, and the risk of sleep disturbance decreased by 47% (RR=0.53).

PubMed: 42500539DOI: 10.3389/fmed.2026.1890318

Mechanism Graph

Intranasal dexmedetomidine is absorbed via nasal mucosa
↓
It acts as a selective alpha-2 adrenergic agonist
↓
It induces a sleep-like state by reducing noradrenergic activity
↓
Result: Improved postoperative sleep quality and reduced sleep disturbance

Limitations

  • ⚠High heterogeneity (I² > 90%) across most outcomes, indicating variability in study designs and populations
  • ⚠Limited number of high-quality trials; more research needed to confirm findings

Frequently Asked Questions

What is intranasal dexmedetomidine?▼

It is a sedative medication administered through the nose, used to promote sleep-like effects without the need for injections.

How much does intranasal dexmedetomidine improve sleep efficiency?▼

Sleep efficiency increased with a standardized mean difference of 1.71 (95% CI 0.94 to 2.48) compared to controls.

Does intranasal dexmedetomidine reduce postoperative sleep disturbance?▼

Yes, the risk of sleep disturbance decreased by 47% (RR=0.53, 95% CI 0.39 to 0.73).

Are there any side effects?▼

Adverse events such as delirium, nausea and vomiting, and anxiety were less common in the dexmedetomidine group compared to controls.

Products

Affiliate links coming soon. We only recommend products that match the doses and forms used in the cited research.

References

  1. 1.Zhao J, Zhang C, Li H, Qiu Y, Li J, Cao H, Zhou X, Guan S, Wang J, Yao M. "Effects of intranasal dexmedetomidine on postoperative sleep quality: a systematic review and meta-analysis of randomized controlled trials.." Frontiers in medicine, 2026. PMID: 42500539 DOI: 10.3389/fmed.2026.1890318
Disclaimer: This content is for educational purposes only and is not medical advice. Evidence scores reflect the quality and quantity of available research, not clinical recommendations. Always consult a healthcare professional before starting any supplement or intervention.